Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8
- 1 July 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (7) , 1390-1393
- https://doi.org/10.1038/sj.leu.2402634
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Chronic Myelogenous LeukemiaJAMA, 2001
- Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activatorBlood, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogeneticsProceedings of the National Academy of Sciences, 2001
- Acute myeloblasts leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosomeBritish Journal of Haematology, 1995
- Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of α-interferon therapy for Ph positive chronic myelocytic leukemiaCancer Genetics and Cytogenetics, 1995
- A second case of trisomy 8 in philadelphia chromosome (Ph)-negative cells during the course of Ph-positive chronic myelocytic leukemiaGenes, Chromosomes and Cancer, 1993
- Trisomy 8 in philadelphia chromosome (ph1)‐negative cells in the course of ph1‐positive chronic myelocytic leukemiaGenes, Chromosomes and Cancer, 1992
- Clonal B lymphocytes lack bcr rearrangement in Ph‐positive chronic myelogenous leukaemiaBritish Journal of Haematology, 1989
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986